Nasdaq
ABVX
Abivax SA
- Health Care
- France
- Listed 2023
- 1 day
- +3.7%
- 1 month
- −8.6%
- 1 year
- +88.2%
$130.00 · Mkt cap $11.2B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Abivax SA
$130.00 · Mkt cap $11.2B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Abivax SA trades under the ticker ABVX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2023. Its market capitalisation is $11.2B. The last closing price was $130.00, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +88.2%, and −8.6% over the past month. Returns are price returns and exclude dividends.
This page exists because ABVX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.